Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 TNP-470 (AGM-1470): mechanisms of action and early clinical development.

× No keyword cloud information.

18 in total

1. The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest.

Authors: J R Yeh; R Mohan; C M Crews
Journal: Proc Natl Acad Sci U S A Date: 2000-11-07 Impact factor: 11.205

2. The role of the vascular phase in solid tumor growth: a historical review.

Authors: D Ribatti; A Vacca; F Dammacco
Journal: Neoplasia Date: 1999-10 Impact factor: 5.715

3. Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice.

Authors: Fabio Montico; Larissa Akemi Kido; Amanda Cia Hetzl; Raísa Mistieri Lorencini; Eduardo Marcelo Cândido; Valéria Helena Alves Cagnon
Journal: Histochem Cell Biol Date: 2014-02-22 Impact factor: 4.304

4. Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model.

Authors: Alison K Esser; Anne H Schmieder; Michael H Ross; Jingyu Xiang; Xinming Su; Grace Cui; Huiying Zhang; Xiaoxia Yang; John S Allen; Todd Williams; Samuel A Wickline; Dipanjan Pan; Gregory M Lanza; Katherine N Weilbaecher
Journal: Nanomedicine Date: 2015-10-27 Impact factor: 5.307

Review 5. Nanomedicine strategies for molecular targets with MRI and optical imaging.

Authors: Dipanjan Pan; Shelton D Caruthers; Junjie Chen; Patrick M Winter; Angana SenPan; Anne H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal: Future Med Chem Date: 2010-03 Impact factor: 3.808

Review 6. Anti-angiogenic treatment strategies for malignant brain tumors.

Authors: M Kirsch; G Schackert; P M Black
Journal: J Neurooncol Date: 2000 Oct-Nov Impact factor: 4.130

7. Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug.

Authors: Dipanjan Pan; Nibedita Sanyal; Anne H Schmieder; Angana Senpan; Benjamin Kim; Xiaoxia Yang; Grace Hu; John S Allen; Richard W Gross; Samuel A Wickline; Gregory M Lanza
Journal: Nanomedicine (Lond) Date: 2012-06-18 Impact factor: 5.307

Review 8. The rationale and future potential of angiogenesis inhibitors in neoplasia.

Authors: G Gasparini
Journal: Drugs Date: 1999-07 Impact factor: 9.546

9. Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.

Authors: Anne H Schmieder; Shelton D Caruthers; Huiying Zhang; Todd A Williams; J David Robertson; Samuel A Wickline; Gregory M Lanza
Journal: FASEB J Date: 2008-08-12 Impact factor: 5.191

10. Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS).

Authors: M Lindskog; P Kogner; F Ponthan; P Schweinhardt; B Sandstedt; T Heiden; G Helms; C Spenger
Journal: Br J Cancer Date: 2003-02-10 Impact factor: 7.640